Clinical trials
Ischemic Stroke clinical trials
Below are recruiting ischemic stroke clinical trials, each written for real people, not researchers. We’re tracking 557 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07874594Recruiting
Brain training to improve sleep after a first stroke
This study tests a treatment that may help reduce brain inflammation and improve sleep in people who have had a first stroke and now have trouble sleeping. It uses a non-invasive technique called remote ischemic conditioning, which involves brief, repeated cycles of a blood pressure cuff on the arm.
Chengdu, SichuanAges 18–80 - NCT06959199Recruiting
Treating stroke beyond 24 hours with artery-opening procedure
This study tests whether opening a blocked large artery in the brain up to 5 days (or even 7 days if symptoms are worsening) after a stroke can improve outcomes. It uses a catheter-based treatment (endovascular therapy) for people who have not responded to standard care and have limited brain damage so far.
Hefei, AnhuiAges 18 years+ - NCT05659160Recruiting
Triage approach for certain strokes from blocked large brain arteries
This trial studies a way to sort and treat people with a specific type of acute ischemic stroke (caused by a blockage in a large brain artery). It may help doctors choose the best next steps—either a procedure or medication—faster and more appropriately.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT05779215Recruiting
Registry for acute stroke with blocked brain arteries
This study records information about people who have a new acute ischemic stroke caused by a blockage in a larger or medium-sized brain artery. It may help doctors better understand outcomes and care for this stroke type, using data from many patients.
Beijing, Beijing MunicipalityAges Any age - NCT04664946Recruiting
Intra-arterial treatment for stroke when no reperfusion was given
This trial tests an “intra-arterial” approach (a treatment delivered through an artery to the brain) for people with ischemic stroke who were not given clot-busting therapy or a clot-removal procedure. It aims to improve neurological recovery when there wasn’t reperfusion therapy, including in cases where symptoms worsen soon after stroke.
ShenyangAges 18 years+ - NCT07207330Recruiting
Stroke code study in Villavicencio hospitals
This trial looks at using a stroke code system in hospitals to improve care for people having a stroke. You may be able to join if you are an adult diagnosed with a stroke by exam and CT scan, as long as it's not caused by injury.
Villavicencio, Meta DepartmentAges 40–100 - NCT06806397Recruiting
Brain imaging study of arm weakness after stroke
This study uses a light-based brain scanner (fNIRS) to understand how stroke affects arm movement. It may help find new ways to improve rehab.
MoscowAges 35–70 - NCT05293080RecruitingPhase 3
Early heart rhythm treatment to help prevent stroke
This trial tests an early treatment approach for people who had a recent ischemic stroke (a stroke caused by a blocked blood vessel) and have an irregular heart rhythm called atrial fibrillation (AF). It aims to lower the chance of having another stroke by treating AF as early as possible after the stroke.
HamburgAges 18 years+ - NCT06316557Recruiting
TMS for memory and thinking after stroke
This trial tests if a gentle brain stimulation treatment (TMS) can help improve memory and thinking after a recent stroke. It is for people who had their first stroke within the last two weeks and have mild cognitive difficulties.
BeijingAges 18 years+ - NCT07672795Recruiting
Clot removal treatment for severe stroke in the back of the brain
This study tests whether a minimally invasive procedure to remove a large blood clot from the main artery at the back of the brain can help people who have had a severe stroke. It aims to improve recovery and reduce disability.
Hefei, AnhuiAges 18–85 - NCT07606807RecruitingPhase 3
New clot-busting medication for stroke in the extended time window
This trial tests a new medication called rhTNK-tPA for treating acute ischemic stroke (a clot in the brain) up to 24 hours after symptom onset. The study uses simplified imaging to determine eligibility and aims to help patients recover better outcomes.
GuangzhouAges 18 years+ - NCT06010641Recruiting
Head-down position for stroke from large artery blockage
This trial tests if lying with the head lower than the body (head-down position) can help people who are having a stroke caused by a blockage in a large artery in the front part of the brain. The goal is to see if this simple position improves blood flow and reduces disability.
ShenyangAges 18 years+ - NCT07375953RecruitingPhase 2
Repeated clot-busting drug for stroke within 3 hours
This trial tests if giving a second dose of a clot-busting drug (tenecteplase) helps people who had a stroke and didn't improve much after the first dose. You must receive the second dose within 4.5 hours of your stroke symptoms starting.
Shenyang, None SelectedAges 18–80 - NCT06403267RecruitingPhase 2
Testing NoNO-42 for moderate to severe ischemic stroke
This study tests a new drug called NoNO-42 for people having a moderate to severe ischemic stroke. You can join if you get clot-busting medicine within 4.5 hours of your stroke and may also have a procedure to remove the clot.
Calgary, AlbertaAges 18–90 - NCT07736885Recruiting
Hand stimulation for thinking problems after stroke
This study tests a gentle, painless electrical stimulation on specific points on the hands to see if it helps improve thinking and memory after a stroke. It is for people who have had a stroke in the last 2 weeks to 6 months and are noticing some cognitive changes.
Tianjin, Tianjin MunicipalityAges 35–80 - NCT07323368Recruiting
Perfusion-guided stroke treatment for medium artery blockages
This trial tests a new way to treat strokes caused by blockages in medium-sized brain arteries within 24 hours of symptom onset. It uses brain imaging to select patients who might benefit from a procedure to remove the clot.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06010628RecruitingPhase 4
Tenecteplase for stroke 4.5 to 6 hours after onset
This trial tests a medicine called tenecteplase (a clot-buster) for people who have a moderate or severe stroke caused by a clot and can be treated 4.5 to 6 hours after symptoms start. It aims to see if this medicine can help improve recovery.
Shenyang, None SelectedAges 18 years+ - NCT07500116Recruiting
Home monitoring after minor stroke or TIA
This study tests whether using a wearable and smartphone app at home can help monitor recovery after a minor stroke or mini-stroke (TIA) – possibly reducing hospital stays while keeping you safe. If you have mild symptoms that stabilized in the ER, and you have help at home, you may qualify.
BarcelonaAges Any age - NCT06194968Recruiting
Stroke treatment with urokinase in real-world settings
This study looks at how well the clot-busting drug urokinase works for treating acute ischemic stroke in everyday medical practice. It may help if you have had a stroke and are eligible for clot-dissolving medication.
Lanzhou, GansuAges 18 years+ - NCT07407790Recruiting
Smartphone heart check after stroke
This study tests whether using a smartphone app to check your heart rhythm after a stroke can find hidden atrial fibrillation (an irregular heartbeat). If you had a recent stroke or TIA and are not already on blood thinners, you may be able to help doctors detect and prevent future strokes.
KristiansandAges 18 years+ - NCT06125236Recruiting
Stroke study for large artery blockages in Southwest China
This study is collecting information from people in Southwest China who have had a stroke caused by a blocked large or medium artery. The goal is to learn more about these strokes and how to treat them better.
LuzhouAges Any age - NCT06548269Recruiting
Assessing stroke recovery in patients with atrial fibrillation
This study watches how people recover from a recent stroke caused by a heart rhythm problem called atrial fibrillation (or AFib). It aims to find better ways to predict recovery and guide future care.
Jinan, ShandongAges 18 years+ - NCT06994975RecruitingPhase 3
Stroke drug test for patients who missed the 4.5 hour window
This trial tests a clot-busting drug for people who had a stroke more than 4.5 hours ago. It uses a special CT scan to see if the treatment can still help them.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06674460RecruitingPhase 3
Edaravone Dexborneol tablet for stroke recovery
This trial tests a new sublingual tablet (Edaravone Dexborneol) to help people recover after a small stroke caused by disease of the small blood vessels in the brain. It aims to see if the drug can improve thinking and daily function.
BeijingAges 30–80
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ischemic stroke?
- Yes. Clin2 currently lists 557 recruiting ischemic stroke studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ischemic stroke trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ischemic stroke trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.